Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study.
Sebastiani M, Venerito V, Laurino E, Gentileschi S, Atzeni F, Canofari C, Andrisani D, Cassone G, Lavista M, D'Alessandro F, Vacchi C, Scardapane A, Frediani B, Cazzato M, Salvarani C, Iannone F, Manfredi A. Sebastiani M, et al. Among authors: frediani b. J Clin Med. 2023 Nov 11;12(22):7041. doi: 10.3390/jcm12227041. J Clin Med. 2023. PMID: 38002655 Free PMC article.
One year in review: novelties in the treatment of rheumatoid arthritis.
Guidelli GM, Barskova T, Brizi MG, Lepri G, Parma A, Talarico R, Cantarini L, Frediani B. Guidelli GM, et al. Among authors: frediani b. Clin Exp Rheumatol. 2015 Jan-Feb;33(1):102-8. Epub 2015 Feb 26. Clin Exp Rheumatol. 2015. PMID: 25719499 Free article. Review.
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.
Bascherini V, Granato C, Lopalco G, Emmi G, Vannozzi L, Bacherini D, Franceschini R, Iannone F, Salerni A, Molinaro F, Messina M, Frediani B, Selmi C, Rigante D, Cantarini L. Bascherini V, et al. Among authors: frediani b. Clin Rheumatol. 2015 Jul;34(7):1171-80. doi: 10.1007/s10067-015-2920-3. Epub 2015 Apr 2. Clin Rheumatol. 2015. PMID: 25833143 Review.
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseasesResponse to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677-1683.
Gentileschi S, Barreca C, Bellisai F, Biasi G, Brizi MG, De Stefano R, Fabbroni M, Fioravanti A, Frati E, Selvi E, Vitale A, Cantarini L, Frediani B, Galeazzi M. Gentileschi S, et al. Among authors: frediani b. Expert Opin Biol Ther. 2016 Oct;16(10):1311-2. doi: 10.1080/14712598.2016.1198765. Epub 2016 Jun 28. Expert Opin Biol Ther. 2016. PMID: 27266338 No abstract available.
One year in review 2016: novelties in the treatment of rheumatoid arthritis.
Calabrò A, Caterino AL, Elefante E, Valentini V, Vitale A, Talarico R, Cantarini L, Frediani B. Calabrò A, et al. Among authors: frediani b. Clin Exp Rheumatol. 2016 May-Jun;34(3):357-72. Epub 2016 May 30. Clin Exp Rheumatol. 2016. PMID: 27268779 Free article. Review.
415 results